Flinton Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$80.7M Sell
277,066
-1,836
-0.7% -$526K 2.5% 4
2019
Q2
$81.9M Sell
278,902
-8,534
-3% -$2.35M 2.58% 4
2019
Q1
$78.7M Buy
287,436
+11,594
+4% +$2.89M 2.58% 4
2018
Q4
$61.7M Buy
275,842
+816
+0.3% +$191K 2.34% 4
2018
Q3
$67.1M Sell
275,026
-16,558
-6% -$3.81M 2.08% 3
2018
Q2
$60.4M Sell
291,584
-8,228
-3% -$1.75M 1.96% 5
2018
Q1
$61.9M Sell
299,812
-612
-0.2% -$128K 2.08% 6
2017
Q4
$57M Buy
300,424
+5,440
+2% +$1.04M 1.94% 5
2017
Q3
$55.8M Sell
294,984
-31,994
-10% -$5.79M 2% 6
2017
Q2
$57M Sell
326,978
-11,424
-3% -$1.92M 2.09% 6
2017
Q1
$52M Sell
338,402
-13,498
-4% -$2.06M 2% 9
2016
Q4
$49.7M Buy
+351,900
New +$51.9M 2.18% 9

Other funds holding TMO

Flinton Capital Management's TMO Position: Q3 2019 in Review

Flinton Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.66% in Q3 2019, selling an estimated $526K and leaving 277,066 shares worth $80.7M. The position accounts for 2.5% of the portfolio, ranked #4.

Flinton Capital Management first reported a position in TMO in Q4 2016 and has held it in 12 quarters since. The position peaked at $81.9M in Q2 2019. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Flinton Capital Management held 277,066 shares of Thermo Fisher Scientific worth $80.7M as of Q3 2019.
  • Flinton Capital Management sold 1,836 Thermo Fisher Scientific shares in Q3 2019, an estimated $526K.
  • Thermo Fisher Scientific made up 2.5% of Flinton Capital Management's portfolio in Q3 2019, its #4 holding.
  • Flinton Capital Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's Thermo Fisher Scientific position peaked at $81.9M in Q2 2019.
  • 1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.